lobbying_activities: 1304291

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1304291	5e4e875c-999a-4d4e-b178-7ef29a1063d8	Q3	AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	3457	AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	2012	third_quarter	PHA	S. 3187, Support for the Drug Shortages provisions within the "Food and Drug Administration Safety and Innovation Act." H.R. 6413, support for the "Transitional Care Act of 2012." Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communications to FDA on approval of biosimilars and drug safety. Communications to Health Resources and Services Administration on 340B drug discount program.	Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE		250000	0	0	2012-10-17T16:56:10.853000-04:00